vTv Therapeutics
VTVT • NASDAQ
vTv Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Paul J. Sekhri, with a market cap of $151.7M.
CEOPaul J. Sekhri
Next Earnings
Upcoming earnings announcement for vTv Therapeutics
Date
Thursday, May 14, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
$0.05
Revenue Estimate
$14.0M
Earnings History
Past 12 earnings reports for vTv Therapeutics
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 10, 2026 | Q4 2025 | -$0.58Est: -$1.04 | +44.2% | - | — |  10-K |
| Nov 6, 2025 | Q3 2025 | -$1.08Est: -$0.98 | -10.2% | - | — | 10-Q |
| Aug 12, 2025 | Q2 2025 | -$0.92Est: -$0.83 | -10.8% | - | — | 10-Q |
| May 15, 2025 | Q1 2025 | -$0.77 | — | - | — | 10-Q |
| Mar 20, 2025 | Q4 2024 | -$0.55 | — | - | — | 10-K |
| Nov 12, 2024 | Q3 2024 | -$0.88 | — | - | — | 10-Q |
| Aug 8, 2024 | Q2 2024 | -$0.81 | — | - | — | 10-Q |
| May 9, 2024 | Q1 2024 | -$1.17 | — | $1.0M | — | 10-Q |
| Mar 13, 2024 | Q4 2023 | -$1.67 | — | - | — | 10-K |
| Nov 9, 2023 | Q3 2023 | -$3.20 | — | - | — | — |
| Aug 11, 2023 | Q2 2023 | -$2.80Est: -$2.80 | 0.0% | - | — | 10-Q |
| May 11, 2023 | Q1 2023 | -$2.40Est: -$3.60 | +33.3% | - | — | — |